Clinical Trials Browser

Phase 1 × Interventional × epratuzumab × Clear all

NCT00054834 2021-08-16

Study of 90Y-hLL2 to Treat Non-Hodgkin's Lymphoma

Phase 1 Terminated

Lymphoma, Non-Hodgkin